KYTX logo

Kyverna Therapeutics, Inc. (KYTX)

Profile

Full Name

Kyverna Therapeutics, Inc.

Ticker

NASDAQ: KYTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 9, 2024

Indexes

Not included

Website

https://kyvernatx.com

Employees

119

Key Details

Price

$6.73(-12.26%)

Market Cap

$294.75M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$3.33(-137.51% YoY)

PE Ratio

-

Next earnings date

Mar 26, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.73
    KYTX price is $6.73

    30-Day Relative Volume

    0.90
    KYTX 30-day relative volume is 0.90

    Price Performance

    Price Most Recent Change

    -12.26%
    KYTX price was down -12.26% on Dec 1, 2025

    Price YTD Change

    +79.95%
    KYTX price is up +79.95% since January 1st

    Price 1-Year Change

    +3.7%
    KYTX price is up +3.7% year-on-year

    Price 3-Year Change

    -
    KYTX price 3-year change is unknown

    Price Range

    Price All-Time High

    $30.60
    KYTX price is currently -78.01% below its historical high of $30.60

    Price 3-Year Low

    $1.78
    KYTX price is currently +278.09% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $294.75M
    KYTX market cap is $294.75 million

    Market Cap 3-Year Change

    -
    KYTX market cap 3-year change is unknown

    Market Cap All-Time High

    $1.30B
    KYTX market cap is currently -77.27% below its historical high of $1.30 billion

    Market Cap Sector Percentile

    55.33%
    KYTX market cap is higher than 55.33% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.45%
    KYTX shares outstanding is up +1.45% year-on-year

    Shares Outstanding 3-Year Change

    -
    KYTX shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.53
    KYTX beta is 1.53

    200-day SMA

    $3.94
    KYTX price is currently +70.91% above its 200-day simple moving average

    50-day SMA

    $6.84
    KYTX price is currently -1.64% below its 50-day simple moving average

    14-Day RSI

    46.74
    KYTX 14-day relative strength index is 46.74

    Volume

    0.90
    KYTX 30-day relative volume is 0.90

    ATR

    $0.70
    KYTX average true range is $0.70

    10-day Historical Volatility

    111.48%
    KYTX 10-day historical volatility is 111.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    KYTX annual revenue is $0.00

    Revenue Analysts Estimate

    -
    KYTX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    KYTX annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.31%
    KYTX annual revenue is higher than 28.31% of companies in Healthcare sector

    EPS

    EPS

    -$3.33
    KYTX annual earnings per share is -$3.33

    EPS Analysts Estimate

    -$3.80
    KYTX annual earnings per share is currently +12.59% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -137.51%
    KYTX annual earnings per share is down -137.51% year-on-year

    EPS Sector Percentile

    28.52%
    KYTX annual earnings per share is higher than 28.52% of companies in Healthcare sector

    Profit

    Gross Profit

    -$2.13M
    KYTX annual gross profit is -$2.13 million

    Gross Margin

    -
    KYTX annual gross profit margin value is unknown

    Operating Profit

    -$142.60M
    KYTX annual operating income is -$142.60 million

    Operating Margin

    -
    KYTX annual operating profit margin value is unknown

    Net Income

    -$127.48M
    KYTX annual net profit is -$127.48 million

    Net Margin

    -
    KYTX annual net profit margin value is unknown

    Expenses

    Total Expenses

    $142.60M
    KYTX annual total expenses is $142.60 million

    Operating Expenses

    $142.60M
    KYTX annual total operating expenses is $142.60 million

    Cost Of Goods Sold

    $2.13M
    KYTX annual cost of goods sold is $2.13 million

    Selling, General & Administrative Expenses

    $30.13M
    KYTX annual SG&A is $30.13 million

    Depreciation & Amortization

    $2.13M
    KYTX annual D&A is $2.13 million

    Interest Expense

    $142.00K
    KYTX annual interest expense is $142.00 thousand

    Income Tax

    $0.00
    KYTX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$127.33M
    KYTX annual earnings before interest & taxes is -$127.33 million

    EBITDA

    -$125.20M
    KYTX annual EBITDA is -$125.20 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $306.52M
    KYTX annual total assets is $306.52 million

    Non Current Assets

    $14.04M
    KYTX annual long term assets is $14.04 million

    Current Assets

    $290.60M
    KYTX annual total current assets is $290.60 million

    Cash and Cash Equivalents

    $96.62M
    KYTX annual cash & cash equivalents is $96.62 million

    Accounts Receivable

    -
    KYTX annual accounts receivable value is unknown

    Inventory

    $0.00
    KYTX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $39.93M
    KYTX annual total liabilities is $39.93 million

    Long Term Liabilities

    $4.30M
    KYTX annual total long term liabilities is $4.30 million

    Current Liabilities

    $33.76M
    KYTX annual current liabilities is $33.76 million

    Accounts Payable

    $4.62M
    KYTX annual accounts payable is $4.62 million

    Debt

    Total Debt

    $8.24M
    KYTX annual total debt is $8.24 million

    Total Debt 1-Year Change

    -9.22%
    KYTX annual total debt is down -9.22% year-on-year

    Long Term Debt

    $4.30M
    KYTX annual long term debt is $4.30 million

    Short Term Debt

    $3.94M
    KYTX annual short term debt is $3.94 million

    Equity & Capital

    Shareholders Equity

    $266.59M
    KYTX annual stockholders equity is $266.59 million

    Book Value

    $266.59M
    KYTX annual book value is $266.59 million

    Retained Earnings

    -$263.52M
    KYTX annual retained earnings is -$263.52 million

    Working Capital

    $256.85M
    KYTX annual working capital is $256.85 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$114.25M
    KYTX annual cash from operations is -$114.25 million

    Cash From Operations 1-Year Change

    -117.99%
    KYTX annual cash from operations is down -117.99% year-on-year

    Cash From Investing

    -$160.90M
    KYTX annual cash from investing is -$160.90 million

    Cash From Investing 1-Year Change

    -1731.55%
    KYTX annual cash from investing is down -1731.55% year-on-year

    Cash From Financing

    $337.11M
    KYTX annual cash from financing is $337.11 million

    Cash From Financing 1-Year Change

    +480.05%
    KYTX annual cash from financing is up +480.05% year-on-year

    CAPEX

    CAPEX

    $2.21M
    KYTX annual capital expenditures is $2.21 million

    CAPEX 1-Year Change

    +255.07%
    KYTX annual capital expenditures is up +255.07% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$116.45M
    KYTX annual free cash flow is -$116.45 million

    Free Cash Flow 1-Year Change

    -119.6%
    KYTX annual free cash flow is down -119.6% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    KYTX annual gross profit margin value is unknown

    Operating Margin

    -
    KYTX annual operating profit margin value is unknown

    Net Margin

    -
    KYTX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -66.79%
    KYTX annual return on assets is -66.79%

    ROE

    -80.74%
    KYTX annual return on equity is -80.74%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    KYTX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    KYTX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.94
    KYTX price to book ratio is 1.94

    PB Ratio Sector Percentile

    50.58%
    KYTX price to book ratio is higher than 50.58% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    KYTX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    KYTX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $128.63M
    KYTX enterprise value is $128.63 million

    Enterprise Value Sector Percentile

    47.73%
    KYTX enterprise value is higher than 47.73% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.76
    KYTX EV/EBITDA is -0.76

    EV/EBITDA Sector Percentile

    49.96%
    KYTX EV/EBITDA is higher than 49.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    8.61
    KYTX annual current ratio is 8.61

    Quick Ratio

    8.61
    KYTX annual quick ratio is 8.61

    Leverage

    Debt To Equity

    0.03
    KYTX annual debt to equity ratio is 0.03

    Interest Coverage Ratio

    -896.73
    KYTX annual interest coverage ratio is -896.73

    Risk & Stability

    F-Score

    -
    KYTX piotroski f-score value is unknown

    Altman Z-Score

    2.86
    KYTX altman z-score is 2.86

    Analyst ratings

    Recent major analysts updates

    Oct 30, 25 Wells Fargo
    Overweight
    Oct 27, 25 HC Wainwright & Co.
    Buy
    Oct 8, 25 Wells Fargo
    Overweight
    Aug 29, 25 HC Wainwright & Co.
    Buy
    Aug 20, 25 William Blair
    Outperform
    May 27, 25 HC Wainwright & Co.
    Buy
    Apr 3, 25 HC Wainwright & Co.
    Neutral
    Apr 1, 25 Morgan Stanley
    Overweight
    Nov 20, 24 HC Wainwright & Co.
    Neutral
    Nov 15, 24 Wells Fargo
    Overweight

    Institutional Ownership

    Screeners with KYTX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Kyverna Therapeutics, Inc.?
    • Does Kyverna Therapeutics, Inc. pay dividends?
    • What sector is Kyverna Therapeutics, Inc. in?
    • What industry is Kyverna Therapeutics, Inc. in?
    • What country is Kyverna Therapeutics, Inc. based in?
    • When did Kyverna Therapeutics, Inc. go public?
    • Is Kyverna Therapeutics, Inc. in the S&P 500?
    • Is Kyverna Therapeutics, Inc. in the NASDAQ 100?
    • Is Kyverna Therapeutics, Inc. in the Dow Jones?
    • When was Kyverna Therapeutics, Inc.'s last earnings report?
    • When does Kyverna Therapeutics, Inc. report earnings?

    What is the ticker symbol for Kyverna Therapeutics, Inc.?

    The ticker symbol for Kyverna Therapeutics, Inc. is NASDAQ:KYTX

    Does Kyverna Therapeutics, Inc. pay dividends?

    No, Kyverna Therapeutics, Inc. does not pay dividends

    What sector is Kyverna Therapeutics, Inc. in?

    Kyverna Therapeutics, Inc. is in the Healthcare sector

    What industry is Kyverna Therapeutics, Inc. in?

    Kyverna Therapeutics, Inc. is in the Biotechnology industry

    What country is Kyverna Therapeutics, Inc. based in?

    Kyverna Therapeutics, Inc. is headquartered in United States

    When did Kyverna Therapeutics, Inc. go public?

    Kyverna Therapeutics, Inc.'s initial public offering (IPO) was on February 9, 2024

    Is Kyverna Therapeutics, Inc. in the S&P 500?

    No, Kyverna Therapeutics, Inc. is not included in the S&P 500 index

    Is Kyverna Therapeutics, Inc. in the NASDAQ 100?

    No, Kyverna Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Kyverna Therapeutics, Inc. in the Dow Jones?

    No, Kyverna Therapeutics, Inc. is not included in the Dow Jones index

    When was Kyverna Therapeutics, Inc.'s last earnings report?

    Kyverna Therapeutics, Inc.'s most recent earnings report was on November 12, 2025

    When does Kyverna Therapeutics, Inc. report earnings?

    The next expected earnings date for Kyverna Therapeutics, Inc. is March 26, 2026
    On this page